September 21, 2020

The Niche

Knoepfler lab stem cell blog

Month: October 2018

3 min read

By Jeanne Loring Stem cells boldly go… Last week at the New York Stem Cell Foundation (NYSCF) conference at Rockefeller University in New York City, we announced our collaborative project to study the effects of microgravity on neurons derived from patient-specific induced pluripotent stem cells.  The press release is here. Susan Solomon, the CEO of NYSCF, announced the unprecedented collaboration:  NYSCF and San Diego’s Summit for Stem Foundation (Summit) are providing the cells and designing the experiment. Space Tango, based in Kentucky, developed the …Read More

3 min read

You probably remember Liveyon. It’s a marketer of an “umbilical cord stem cell” product that was recently recalled by the FDA. The recall was due to adverse events that may have included E. coli contamination somewhere before it was injected into patients, some of whom apparently got sick. Since it seemed like this recalled product was a major part of Liveyon’s business model, some wondered: could the company survive the recall? My sense at the time was that it would just find another source for …Read More

3 min read

Remember when the Piero Anversa situation first made news or at least when you first heard about it? In the public domain, it was back around April 2014. I didn’t even do a whole post on it, but rather it made two bullet points in a post about a set of bad overall news including the latest at the time on the growing mess from STAP cells.  However, clearly there were concerns about this Anversa thing well before 2014. What took so long? In my 2014 post here …Read More

2 min read

Take our poll: what will be the fates of the stem cell clinic firms sued by the FDA one year from now in October 2019? To be clear, I am asking for your predictions, not what you hope will be the situation a year from now. U.S. Stem Cell, Inc. (USRM) and California Stem Cell Treatment Center along with its parent stem cell clinic chain Cell Surgical Network were separately but in parallel sued in May by the FDA via the DOJ seeking permanent injunctions …Read More